CANY
TCRR

Caxton Associates (New York)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Caxton Associates (New York)’s Portfolio TCRR Stock Details TCRR Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,784
Closed -$106K – 728
2021
Q4 		$106K Buy
+22,784
New +$106K 0.01% 497